Literature DB >> 17425745

The fate of recipient-derived hepatocytes in sex-mismatched liver allograft following liver transplantation.

Ramazan Idilman1, Esra Erden, Isinsu Kuzu, Sadik Ersoz, Selim Karayalcin.   

Abstract

BACKGROUND: ''Bone marrow-derived stem cells'' have attracted great attention as potential candidates for liver-directed gene therapy and as a tool for regenerative medicine. However, the fate of these cells is not well-known. The aim of this present study was to investigate the fate of ''recipient-derived repopulated hepatocytes'' in sex-mismatched liver allografts in individuals following liver transplantation during systematic longitudinally performed liver biopsies.
METHODS: Paraffin-embedded sex-mismatched liver biopsy samples of nine recipients (male/female ratio 5/4; mean age: 39.7 yr) were reviewed. Double labeling with immunohistochemistry for hepatocytes and recipient-specific bone marrow-derived cells and fluorescence in-situ hybridization for visualizing X and Y chromosomes were performed. These slides were examined systematically using an image analyzer system (Olympus microscope; Cyto-Vision, Applied Imaging, Biosciences Centre, Newcastle, UK). Only cells with two nuclear spots were considered for interpretation.
RESULTS: The mean times from transplantation to first biopsy and between the first and the second biopsies were 5.9 and 20.9 months respectively. The proportion of recipient-derived repopulated hepatocytes was significantly decreased in the late biopsies when compared with the early biopsies (p = 0.001). All nine samples of the first biopsies had demonstrated recipient-derived hepatocyte repopulation, with a mean of 2.0%, whereas only seven of nine samples of the second biopsies had demonstrated recipient-derived hepatocyte repopulation with a low mean of 0.5% (p = 0.001).
CONCLUSION: Based on these results, we suggest that ''recipient-specific bone marrow-derived hepatocyte repopulation'' in liver allograft during tissue injury is a relatively early event.

Entities:  

Mesh:

Year:  2007        PMID: 17425745     DOI: 10.1111/j.1399-0012.2006.00623.x

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  7 in total

Review 1.  Stem cell therapy for inherited metabolic disorders of the liver.

Authors:  Susan Ellor; Thomas Shupe; Bryon Petersen
Journal:  Exp Hematol       Date:  2008-04-02       Impact factor: 3.084

2.  Mobilization of host stem cells enables long-term liver transplant acceptance in a strongly rejecting rat strain combination.

Authors:  T Okabayashi; A M Cameron; M Hisada; R A Montgomery; G M Williams; Z Sun
Journal:  Am J Transplant       Date:  2011-08-30       Impact factor: 8.086

Review 3.  Potentials of regenerative medicine for liver disease.

Authors:  Shinichiro Ogawa; Shinichi Miyagawa
Journal:  Surg Today       Date:  2009-12-08       Impact factor: 2.549

4.  Evidence for Recipient-Derived Cells in Peribiliary Glands and Biliary Epithelium of the Large Donor Bile Ducts After Liver Transplantation.

Authors:  Iris E M de Jong; Michael E Sutton; Marius C van den Heuvel; Annette S H Gouw; Robert J Porte
Journal:  Front Cell Dev Biol       Date:  2020-08-05

5.  Chimeric Allografts Induced by Short-Term Treatment With Stem Cell-Mobilizing Agents Result in Long-Term Kidney Transplant Survival Without Immunosuppression: A Study in Rats.

Authors:  X Hu; T Okabayashi; A M Cameron; Y Wang; M Hisada; J Li; L C Raccusen; Q Zheng; R A Montgomery; G M Williams; Z Sun
Journal:  Am J Transplant       Date:  2016-02-26       Impact factor: 8.086

6.  Recruitment of host progenitor cells in rat liver transplants.

Authors:  Zhaoli Sun; Xiuying Zhang; Jayme E Locke; Qizhi Zheng; Shingo Tachibana; Anna Mae Diehl; George Melville Williams
Journal:  Hepatology       Date:  2009-02       Impact factor: 17.425

Review 7.  Implication for bone marrow derived stem cells in hepatocyte regeneration after orthotopic liver transplantation.

Authors:  N Pilat; L Unger; G A Berlakovich
Journal:  Int J Hepatol       Date:  2013-09-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.